신라젠 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 조환우, was filed 02 Jul 2025.
신라젠: what insiders have been doing
신라젠 is a Health Care company. Its directors and officers file their transactions with DART (FSS). In the past year (31 October 2025 to 31 October 2026), 1 filing came from 1 insider.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
No insider has bought 신라젠 shares on the open market in the past twelve months.
Compared with its exchange (2,655 companies, median 7 filings), a count of 1 filing is below the norm. Since 2021, the database holds 18 purchases and 1 sale by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0DART
- 762,711 sharesShareKRXDART:20250702000585Canonical exit: 30 Sept 2025 (T+90)
- 0KRXDART:20240701000596
- ShareKRXDART:20240701000357Canonical exit: 24 Sept 2024 (T+90)
- ShareKRXDART:20240701000348Canonical exit: 24 Sept 2024 (T+90)
- 2,983,232 sharesKRXDART:20240610000395Canonical exit: 28 Aug 2024 (T+90)
- 2,983,232 sharesKRXDART:20240607000419Canonical exit: 28 Aug 2024 (T+90)
- ●Executives0DART
- 3,737,069 sharesKRXDART:20230118000434
- 2,983,232 sharesKRXDART:20221220000328Canonical exit: 20 Mar 2023 (T+90)
- 2,983,232 sharesKRXDART:20221117000310Canonical exit: 15 Feb 2023 (T+90)
- 2,983,232 sharesKRXDART:20221117000178Canonical exit: 15 Feb 2023 (T+90)
- 2,983,232 sharesKRXDART:20221115000238Canonical exit: 13 Feb 2023 (T+90)
- ShareKRXDART:20221115000234Canonical exit: 13 Feb 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 2,983,232 sharesKRXDART:20211105000401Canonical exit: 3 Feb 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
- 2,983,232 sharesKRXDART:20210913000294Canonical exit: 12 Dec 2021 (T+90)
- 2,983,232 sharesKRXDART:20210906000199Canonical exit: 5 Dec 2021 (T+90)
25 of 34 declarations
About 신라젠
신라젠 is a biotechnology company focused on developing cancer treatments. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
